Stock Taper
Scilex Holding Company, a Palo Alto-based biopharmaceutical firm and Sorrento subsidiary, develops non-opioid pain therapies, including ZTlido for neuropathic pain and various products in clinical trials for conditions like radiculopathy, back pai...

GLOPERBA® is the FDA-approved liquid colchicine for gout flare prevention, launched in June 2024, offering flexible dosing for adults, especially those with renal or hepatic impairment.
Overall rating: C
| PEER | PRICE | |
|---|---|---|
RVMD | $209.46 | COMPARE |
ADAG | $4.02 | COMPARE |
ACET | $9.19 | COMPARE |
GANX | $2.00 | COMPARE |
NRXP | $3.56 | COMPARE |
DXR | $10.00 | COMPARE |
LITS | $0.99 | COMPARE |
CRVO | $2.62 | COMPARE |